Here's Wouldn't Touch Canopy: Why I Pass in 2026 and Beyond
Cannabis stocks remain volatile and Canopy Growth sits at a crossroads in 2026. This article explains why many invest...
Identify the mix that offers broader exposure for retirement by comparing Sp500 and total market allocations and adjusting for risk.
28,595 articlesCannabis stocks remain volatile and Canopy Growth sits at a crossroads in 2026. This article explains why many invest...
Ark Invest's July activity shows notable interest in Kratos Defense. This article breaks down what the buys mean, the...
XRP has fallen from recent highs, but a rebound back above $2 is on the table if key catalysts align. This guide brea...
As April 10 approaches, investors debate whether Lilly stock is a buy. This guide breaks down catalysts, valuation, a...
Top U.S. homebuilders are backing Avila Real Estate Capital’s AREC Fund II, signaling a shift in housing finance as b...
Copart director Daniel Englander recently sold 80,000 shares for about $2.2 million. With CPRT down roughly 40%, inve...
Hynix’s move onto the Nasdaq marks a watershed moment for foreign listings in the U.S. tech space. This article break...
Could Tesla ride a $10 trillion wave of opportunity before 2029? This analysis breaks down the bets, the risks, and p...
A little-known tax lane lets some investors pocket long-term gains tax-free. As 2026 unfolds, careful planning can un...
Investors are buzzing about United States Antimony as shipments update boosts sentiment. This article breaks down the...
Pi Network’s PI surged to a 3-month high near $0.23 as Bitcoin hovered around $68,000 this weekend, marking a rare br...
Is Pfizer stock undervalued in the crowded healthcare space? This deep dive weighs cash flow, dividends, pipeline pot...